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The current study was undertaken to determine the 
mechanism by which the retinoid all-tralls-retinoic 
acid regulates procd(I) collagen gene expression in 
fetal rat skin fibroblasts. FRS fibroblasts were stably 
transfected with the ColCat3.6 plasmid, which con-
tains a portion of the 5' flanking region of the rat 
proa1(I) collagen gene linked to a reporter gene, 
chloramphenicol acetyltransferase. The effect of 
t-RA on CAT activity was determined as a function of 
concentration and incubation time. Maximal inhibi-
tion of CAT activity by t-RA occurred at 10- 8 M after 
48 h of treatment. Transforming growth factor-JH 
did not block the inhibitory effect of t-RA on CAT 
activity. Computer sequence analysis of the 3.6-kb 
DNA fragment that contains the promoter for the rat 
proa1(I) collagen gene identified a direct repeat 
RARE sequence composed of one diverse (5' -AG-
T AGA-3') and one idealized (5' -GGGTCA-3') half site 
located at positions -1345 and -1335, respectively. 
R etinoic acid, a vitamin A derivative, is an important modula to r of cellul ar growth, differentiation , and dev~ lopment in vertebrate o. rgallisl.11S .. Pre~ iou s studies have shown that all-tralis-re tU101c aCId (t-RA) decreases procoUagen prod uction in human 
skin fibro blasts and in fibroblast ce lJ lines derived fro m ke lo ids 
(Oikarinen el ai, 1985). Keloid-derived fibrobl ast cultures have 
bcen shown to ha ve an enhanced rate of co llagen synth esis 
(Diegel mann et ai, J 979; Ala-Kokko et ai, J 987; Abergel and Uitto, 
1989). t-RA se lectively decreases procoll agen synthesis and the 
steady-state levels of proa2(1) collagen mR.NA in keloid cell lines 
(Oikarincn et ai, 1985). T he steady-state levels ofproa1 (I) collagen 
mRNA in human ·Iun g fi broblast cultures are also decreased by 
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Two nuclea.r retinoid receptors that were expressed 
in bacteria, retinoic acid receptor-y and retinoid X 
receptor-a, were found to bind specifically to a dou-
ble-stranded oligonucleotide containing the RARE 
in gel mobility shift assays. Mutation of the idealized 
half-site eliminated the binding of receptor proteins 
to the oligonucleotide. Gel mobility shift assays using 
nuclear protein extracts prepared froln t-RA-treated 
FRS fibroblasts showed that binding to the oligonu-
cleotide containing the RARE was decreased from 
control values. The same assays performed with the 
mutated oligonucleotide resulted in only slight bind-
ing. These studies indicate that t-RA downregulates 
the promoter activity of the rat proa1(I) collagen 
gene by decreasing the binding of nuclear protein to 
the RARE sequence in the 5' flanking region of the 
gene. Key lVol'ds: keioidslpl'ocollage"ltl'amformitlg gl'orvtlr 
factor-{31. ] f'lllest Del'llla.tol 108:476-481, 1997 
t-RA, with a concomitant decrease of proa1 (I) gene transcription 
as determined by nucl ear run-off assays (Krupsky et ai, 1994). 
T he e lFects of t-RA are bcli eved to be mcdiated by nuclear 
retinoid receptors , which function as li gand-activated transcription 
factors and are members of thc steroid/thyroid ho rmone receptor 
superfamily (Evans, 1988; Wah li and M artinez, 1991). Two [;lI1U-
lies of nuclear retinoid receptors have been identifi ed: the retinoic 
acid receptors (RARs) and the reti noid X receptors (RXRs). The 
RARs and the R.XRs consist of three homo logous sub types, a , {J, 
and l' (Petkovich el ai , 1987; Brand et ai, 1988; Krust cl (/1, 1989; 
Mangelsdorf el ai, 1990; Leid et (II, 1992a). RAR.s bind t- RA and 
9-cis-retinoic ac id , whereas R X R s bind on ly to 9-cis-rctin~ic acid 
(Levin et ai, 1992; All en by et ai, 1993). RARs and R.XRs form 
heterodimers that, when ligand is present, regu late the expression 
o f specific genes (Leid el ai, 1992; All enby et ai, 1993). T he 
ligand-activated nuclear re tinoid receptors mo dulate gene e;o.:pres-
sio n by bindin g to specific DNA sequences ca ll ed retinoic acid 
response elem ents (RAllis) (De Luca, 1991; Glass et ai, 1991) . T he 
RAllis consist of repe titive half-sites that are o rganized into direct 
repeats, p~llindromes, o r inverted palindromcs with varying spacing 
between the half- sites. T he consensus half-s ite seq uence is 5' - (A/ 
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G)G(G/T)TCA-3'; however , variations in the ideal sequences have 
b een observed (Glass et ai, 1991 ; G udas, 1992; Leid e/ ai , 1992b). 
In the current study, a RARE seque n ce was identifie d in the 
proal (I) collagen pro moter b y compute r seque n ce analysis. An 
o ligonucleo tide containing the ide ntified sequence w as found to 
bind bacterially expressed R.AR y and RXRa in ge l mobiLity shift 
assays, confirming the existe n ce of a RARE in the proa l (1) 
colJagen promoter. Nuclear pro te in extracts iso lated !Tom t-RA-
tr eated feta l rat skin (FRS) fibrob las ts showed d ecreased binding to 
the RARE as compare d to binding of extrac ts prepared fro111 
untreated ce lJ s. T he d ecreased binding to the RARE may in part b e 
responsible for the t-RA-mediate d downregula tiol1 of procolJagen 
gen e express ion. 
MATER.I A.LS AND METHODS 
Retinoids and Transforming Growth Factor-{3 (TGF-f3) t- I~ was 
purchased fro m Sigma (St. Louis, MO) . TGF-{31 was purchascd from R & 
D Systcms (Minneapoli s, MN). Lyophili zed samples of TGF-{3 1 were 
reconstituted in 4 mM H C I containing 1 mg bovine serllm albumin per ml. 
t-RA was disso lved in d imethyl sulfoxide and stored in liquid nitrogen . 
Cell Culture Methods FR.S fibrob lasts wcre purchased from the Amer-
ican Typc C ul tlll'c Collection (C RL 1213, batch F-9707), R ockville, MD . 
FRS ce lls were grown in 90% (vollvol) Dulbecco's modifi ed Eagle ' s 
medium (Whittakcr M.A . Bioproducts, W alkersv ille, MD), 1 (J'Yo (vo l/ vo l) 
heat-inactivated fcta l bovine SCHill I (Hyclonc, Logan. UT) . 100 units 
penicillin per ml , and 1 (JO J.Lg streptom ycin per ml. Prior to treatment, the 
ce ll s were washed twice with AIM V (GIDCO BR.L, Grand Island , NY), a 
syn thetic serum-lice medium. The ce lls were treated with t-IU or TGF-{31 
in AIM V medium . Contro l cultures were treated wi th the vehicle used to 
dissolve thc respcctivc compounds. T he conccntration of dimcthyl sulfox-
ide in the ITICdi uI11 '.vas 0. 1 'Yu. Expclinl c l1 ts in which cell s ,.vere treated w-ith 
retino ids were performed under yellow lights. 
Transfcction of FRS Fibroblasts and Stable Selection Cclls wcre 
transfected by using thc ca.lcium phosphate co-precipitation method (Chen 
and Okayma , J 987). Plasmids wcre purificd by double CsCI banding 
according to standard methods. ColCat3.6 (suppl ied by D.Rowe and 
A . Lichtler, Univcrsity of Connccticut Health Science Centcr, Farmington, 
CT) conta ining the rat proal (I) colhlgen promoter was tra nsfected into FRS 
ce lls. T he pSV2neo plasmid was co-transfected for sta ble ce ll se lection 
(Gorman el til. '1 982 ; Southern and Bcrg, 1982; Lichtler cf ti l , 1989; 
Ritzcnthaler cf til, 199 1) . Stable transfections were uscd since reproducible 
res uJts wcre not obta incd by using transien t tra nsfections for glucocorticoid-
trea ted cell s. Cc ll s were sel ectcd with G4 18 (200 /Lg per ml). 
Preparation ofCcll Lysates and Assay of Chloramphenicol Acctyl-
transfcrasc (CAT) Activity At thc appropriate time after treatment, 
cc lls we rc placed on ice and washed three ti mes with icc-co ld phosphate-
buffercd sa l.ine (G II3CO mu, Grand Island. NY) . Cell s were harvested in 
1. ml of 40 mM Tris(hyd roxYll1cthyl)aminol1lethanc (Tris)-HCI, pH 7 .4, 150 
mM NoCl, and 1 mM eth)'lenediamine tetraacetic acid at 4°C as described 
(Gorman et til, 1982) . CAT activity was dercrmined by modification of an 
established method (Neumann ct ti l, '1 987). T he same amount ofprotcin was 
added to each reaction mixture contained in 50 J.LI of 1 00 mM Tris-HCI, pH 
7.8. Two hundred micro li te rs of 1.25 mM chlo ramphenicol in 100 mM 
Tris-H C I, pH 7.8, were added along with 0.5 J.LCi of [3HJacctyl-CoA (200 
mCi/mmol, DuPont NEN. Boston. MA) and 22.5 J.LI of 1 mM unlabelcd 
aceryl-CoA (Sigma, St. Louis, MO). The en tire reaction mixture was 
overlaid with liquid scintillation Au id (EconoAuor-2, DuPont NEN). T his 
assay allows mul tip lc time point determinations by liquid scintilla tio n 
co unting. T he acetylated chloramphenicol product is misc ible in the 
a q u eous-itnl11isci bl c scint.ill at io n coun ting rnixture . T i1l1!.! course activi ty of 
each sample was determined and onl y activity in the li near range of the time 
course '.vas used. W ithin each assay. data fro nl the sa nl C tit11e point \verc 
reportcd fo r all samples. Protein concentrations of cell Iysates were deter-
min ed. (Lowry d ti l . 195'1) . 
DNA Mobility Shift Assays ConAuent FRS fibro blas ts were washed 
twice with ArM v medium . T he cclls were trea ted with t-R.A (fina l 
concentration, 10- " M) in AIM V medium . Control cell s received the 
vehicle dimethyl sulfoxidc (O.l'X,) used to di ssolve t- I~A. Nuclcar extracts 
wcre preparcd according to the method of Andrews and Fa ller ('1991) and 
the protein concentration was determined (Lowry ct til. 195 1). 
Singlc-strandcd oligonucleotides containing the COlISe\1SUS I~RE half-
site sequence (5 ' -GGGTCA-3') or a sequence in which thc six bases were 
changed (5'-TATGAC-3') wcrc synthesizcd by Integratcd DNA Techno l-
ogies (Coralville, IA) . T he sequencc containing the altered bascs is referred 
'" I 
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Figure 1. Maximal inhibition of proa1(I) collagcn promotcr activ-
ity occurs at 10- 8 M t-RA. Stable FRS fibroblasts transfccted with 
ColCat3.6 were examined for dose dependence to t-I~. ConAucnt cell s 
were cxposed to 10- 6 , 10- 7 , 10- 6 , or 10- ') M t-RA for 48 h. Ccll Iysa tes 
'were assaycd for CAT activ ity, '\lh.ich is expressed as co unts pCI' 1l1in per t-Lg 
of protein. *Significancly diffcrcnt fro m contro l values at p < 0.05 . En'or 
bars, SEM (II = 3). 
to as the mutatcd retinoic ac id rcsponse element (m l~RE). T he entire 
sequcnccs of the oligonucleotidcs arc li sted in the legends CO Figs 4-7 . 
Twenty micrograms of the single-stranded oligonucleotides werc annea led 
with 20 /Lg of their complementary strands in 200 mM N aCI by heating CO 
95°C fo r 7 min and then slowly cooled to 4°C. T he doublc-stranded 
o ligonucleotides were sto red at - 20°C . Double-strandcd oligonucleotides. 
RAR conse ll sus o ligonucleotide, and RXR consensus oligonucleotide 
(Santa C I'l1 Z Biotechno logy, Santa C ruz. CAl were "Iso used as DNA 
probes. T hc sequences of these probes arc listed i.n the legends to Figs 5 and 
7 . 
T he o ligonuclcotides were labeled with J2 p by using the 5' DNA 
Terminus Labeling System (GIBCO BRI., Gaithersburg, MD). Gel shift 
binding reactions (20 J.LI) conta ined 32P_e nd_labeled double-stranded oligo-
nuclcotide with thc RARE o r ml~RE sequencc (2- 3 X 10" cpm per 
pmol). 10 J.Lg ofnudear protein extract, 1.5 J.Lg of poly[d(I-C)] (Pharmacia, 
Piscataway. Nj), 90 mM KCI, 1 mM eth)'lenediamine tetraacetic acid. I 111M 
dithiothreitol. and 5% glycero l. In sOll1e assays. 50 ng of thc bacterial-
expresscd receptor proteins RAR y or RXRa (obtained from Dr. j en-Fu 
C hiu , Universiry 0[Ven11Ont, Burlington, VT) wcre used instead of nuclear 
protein extract. In othcr experiments, I~Ry prote in purifi ed fro m bactcri al 
Iysates was ob tained from Santa C I'l1Z Biotcchnology. Reaction mix turcs 
'were incubated for 30 n1in at r00l11 tCIllperaturc and sepa rated 0 11 61% 
po lyacrylamide gels (19:1 acrylamidc to bisacrylamide) in 0.25 X TBE buffer 
[89 mM Tris boratc, 89 mM bori c acid. 2 mM ethylenediamine tetraacetic 
acid (pH 8.0)] for 4 h itt 100 V. Thc gels were air-dried and autoradio-
graphed. T he band intensities of the bound protein- DNA complexcs were 
111 casured by dcnsio l11ctric analysis llsing a Shjnlndzll dual-,vavc1engch 
thin-laye r chroma tof,'Taphy scanner, model CS-930 (ShimadzlI , Kyoto. 
j apan) . Competition cxperimcnts were performed by the addition of 
unlabelcd I~Alli or I~R consensus o 1.igonucleotide to rcaction mixtures. 
In gel supershift assays, RARy antibody (Santa C ru z Biotcchnology) was 
added to reaction mixtures subsequcnt to a 20-l11in incubation of the 
o ligonucleotide probe 1~ I~E with I~R y protein. Incubation was contin-
ued for an additional 45 min at room temperaturc. 
Statistical Analysis Sig ni fi cance of diffcrcllcesin Inea ns was dctcrnljned 
by Studcnt' s t test. 
RESU LTS 
t-RA Decreases Rat Proa1(I) Collagen Promoter Activ ity in 
Stable FRS Fibroblast Cell Lines FR S fibroblasts sta bl y trans-
fected with ColCat3.6 sh owed a d ecrease in CAT activity when 
treated with t-RA fo r 48 h (Fig 1). At 10 - 8 M t-RA, there W :1S a 
65'Yo decrease in CAT activity. In creasin g the con centration of 
retinoid to 10 - 7 M and 10 - 6 M did not inc rease the inhjbitory effect 
of t-RA . At 1 O - ~ M t-RA, the cell line did n o t demonstrate a 
statistica lly significant d ecrease in proal (I) collagen promote r 
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Figure 2. t-RA decreases and TGF-{:!l increases proal(I) collagen 
promoter activity in stablc FRS fibroblasts . Stable FRS fibrob lasts 
transfected w ith ColCat3.6 were examined for responsiveness to t-R.A. 
TGF-{:ll. or t-RA plus TGF-{31. ConAu cnt ce ll s were treated with 10- (' M 
t-RA, 5.0 ng TGF-{:ll per mi. or 10- (' M t-RA plus 5.0 ng TGF-{:l1 per ml 
fo r 48 h. Cell Iysutcs wcre assuyed for CAT activi ty, which is expressed as 
counts per min per j.Lg of protein. *Signifi cantly di fferent from contro l 
values at p < 0.01. Error bars, SEM (n = 3 or 4). 
acti vity. Similar resu lts were o btained with a second stable cell lin e 
transfected with CoI C~lt3.6 (data not shown). When a stable ce lJ 
line transfec ted with ColCat3.6 was trcated with lO - () M t-RA for 
24 h . there was no significan t decrease in promoter activity. T he 
signifi cant decrease in pro m oter activity observed after 48 h of 
incubation with 1. 0 - 6 M t-RA was m ai.ntain cd for 3n additional 
48 h (data not shown). 
In a previous study, we showcd that dcxamethason e down-
regu lates procoll agen gene expression by measuring the decrease in 
CAT activity in cell lysates prepared from dexamethasone- trcated 
FRS fibroblasts stably transfected with CoICat3.6. We proposed 
that g lucocorticoids coordin ate ly regu late procollagen gene expres-
sion thro ug h bo th the g lucocorticoid response e lement and the 
TGF-{3 e lement (Meisler e/ ai, 1995). A g lucocorticoid response 
element sequence is located at positions -655 to -650 and a TGF-{3 
element is located at position - 1628 upstream fi'om the start sitc of 
transcription in the rat proal (I) collagen promoter (Lichtler e/ ai, 1989; 
Ritzcnthaler et ai, 1991, 1.993). Computer sequence analysis of thc 
portion of tllC 5' Ranking region of the rat proal (I) colJagen gene in 
the CoICat3.6 plasmid rcvealed a sequcncc m atched to thc consensus 
RARE half- sitc, 5 '-(A/G)G(G/T)TCA-3 , (Leid c/ ai, 1992b). T he 
6-bp sequence is 5'-GGGTCA-3' and is located at positions - 1335 to 
- 1330 from the start site of transcription in the rat proal (I) colJagen 
promoter. There is a closely related 6-bp sequence to thc consensus 
RARE half-site, 5' -A GTAGA-3 ', located at positions - 1345 to 
-1340. T hese two sequences are separated by 4 bp. The sequence 
from positions -1345 to - 1330 is refen:ed to as the RARE. 
TGF-f3 Does Not Block the Decrease in Proa1(I) Collagen 
Promoter Activity Caused by t-RA Tn a previous study, 
concurrent TGF-{31 treatment was able to bring the o bscrved 
dexamethasone-mediated decrease in CAT activity back to the 
control va lue (Meisler el ai, 1995) . In this study, addition of 
TGF-{31 to the culture medium did not block the inh.ibitory effect 
of variou s concentrations oft-RA on CAT activity . TGF-{31 (5 .0 ng 
per ml) treatment alo ne ca used a 1.8-fold increase in CAT activ ity . 
In a previous studyin g usin g NIH 3T3 celJs, TGF-{31 treatment 
a lone resttlted in an approximate ly 2-fold in crease in proal (I) 
coUagen promoter activity Oimenez el ai, 1994). t-RA at a concen-
tration of 10 - c, M ca used a decrease in CAT activ ity of 51%, 
whereas the combinati.on of 10 - <> M t-RA plus 5.0 ng TGF-{31 per 
ml e lic ited a 44% decrease in CAT activity (Fig 2). Furthermore, 
addition of 5.0 n g TGF-{3l per ml to ceUs treated simultaneo usly 
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F igurc 3. TGF-{:!l does not block the t-RA-mcdiatcd dccrcasc in 
proll'l(I) collagen promotcr ac tivity in stable FRS fibroblasts at 
various conccntrations oft-RA. Stable FRS fibrobhlsts transfected with 
Co1Cat3.G were examined for responsiveness to t- I~. TGF-{:ll, or t-RA 
plus TGF-{:ll. ConAuent cell s we re treated w ith 10- 9 M 2.5 X 10- 9 M 
- f) - ij . • • 
7.5 X 10M. or 10 M t-RA plus or mlllll S 5.0 ng TGF-{:l1 per ml for 
48 h. Ce ll Iysates we re assayed for CAT activity, w hich is expressed as 
coun ts per min per j.Lg af pro tcin. D. t-RA-treatcd ce ll cultures; !1!il , t-RA + 
TGF-{:l l (5.0 ng per m l)-treated cell cu ltures. ' Significantly diflcrent from 
contro l va lues (no additio n oft-RA o r TGF-{:l1) at p < 0.01 . Em". bm:l, SEM 
(n = 3 or 4). 
w ith t-RA at concentrations between 1 0 - ~ M and 10 - 9 M did not 
bl o~: the t-RA-mediated decrease in CAT activity (Fig 3) . At 
10M t-RA, there was a 59% decrease in proal (1) collagen 
promoter activity, and in the presence of TGF-{31, thc decrease in 
CAT activity was 73%. Similar decreases in promoter activity were 
found, respectively, when the concentration of t-RA was 7.5 X 
10 - " M or 2.5 X 1 O - ~ M . At 10 - 9 M t-RA. th ere was no 
signifi cant decrease in CAT activity, w hich agrecs with the data 
s h ~,:", n in Fig 1, but the com bin ation of 5.0 ng TGF-{3l per ml and 
10 9 M t-RA caused a 54'1., decrease in proal (I) collagen promoter 
activity . T hus even at concentrations of t-RA below the physio-
logic serum concentrations of 1.0 - 7 M to 10 - H M (Adamson e/ al. 
'1992) , addition of TGF-{31 did not abrogate the t-R.A-mediated 
de.crease in proal (I) collagen promoter activity. Tn a previolls study 
usmg human lung fibroblasts, t-RA treatment inhibited basal and 
TGF-{31-stimulated collagen synthesis. When fibrob lasts were 
incubated with TGF- {31 and t-RA, there was a decrease in cd (I) 
colJagen mRNA accumu lation and gen e transcription (Redlich el 
ai, 1995) . . 
RARI' and RXRa bind to a cis-Elemcnt in the 5 ' F lanking 
region of the R at Proa1(I) Collagen Gcne BacteriaUy ex-
pressed receptor prote ins R A R. l' and lURa were used in gel 
mobili ty shift assays to identify a RARE in the rat a l (I) collagen 
promoter. When the 32P_l abeled o ligonucleotide 5'-AAGTA-
GAGTGGGGGTCAGGCAGAGCACC-3' (located in the pro-
moter from positions - 1346 to - 1319) was llsed as a probe, 
binding was o bserved with both RAR l' and RXRa protein (Fig 4) . 
T here was an absence of binding with unprogrammed bacterial 
lysate. When the 6-bp sequence 5' -GGGTCA-3' (consensus 
RARE half-site seq uence) was replaced with th e seq uence 5 ' -
TATGAC-3 ' (mutated RARE hal f- site seq uence), the RARy and 
RXRa p roteins no longer bound to the o ligonucleotide. These 
resu lts indicate that the sequen ce from positions -1335 to - 1330 
(5' -GGGTCA-3 ') in the proal (I) coll agen pro moter is a RARE 
hal f- site. BacteriaUy expressed RAR l' and RXRa bo und in a 
similar pattern to a RARE identificd in the 5' Ranking region of the 
rat a-fetoprotein gene (Liu c/ ai, 1.994). 
Addition of RAR l' Antibody Causcs a Supcrshift of the 
RAR I'-RARE Complex RAR y-purified protein prod uced in 
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Control RARy RXRIl RARy RXRIl Lysate 
Figurc 4. Bactcrially SYlldlcsizcd RAR 'Y and R.XRa binds to a 
RARE in thc proal(I) collagcn promotcr. Gel mobility shjft assays 
were performcd with 32P_cnd_labeled double-stranded oligonucleotide 
contajning the RARE half-site sequence (5' -GGGTCA-3 ' ) (2.3 X 106 cpm 
per pmol) or the mRARE half-site sequencc (S ' -TATGAC-Y ) (2.8 X 106 
cpm per pmol) and 50 ng of bacterially expressed RAR'Y or RXRa. The 
32P-labeled probe containing the RARE sequence was also incubated with 
unprogrammcd bacterial lysate as control. In addition. each assny mixture 
contained 0.2 ILg of poly[d(I-C)] and 6 ILg of bovine serum albumin in a 
rotal volume of20 ILl. Complete sequence of the oligonucleotide contajning 
the RARE in the rat proa l (I) collagen promoter from positions - 1346 to 
- 1319 (5 ' -AAGTAGAGTGGGGGTCAGGCAGAGCACC-3 ' ); complete 
sequence of the oligonucleotide containing the mRAR.E (5 ' -AAGTA-
GAGTGGTA TGACGGCAGAGCACC-3 '). 
Escherichia coli for use as a posll:lve control for gel shift studies 
formed a complex with the RARE in the rat proal (I) collagen 
promoter. Addjtion of an antibody to RAR y gave rise to a 
supershifted band (Fig SA) . In the presence of the antibody, an 
antibody-protein-DNA complex was form ed that resulted in a 
further reduction in the mobility of the RAR y-RARE complex. In 
a competition experiment, RAR y was incubated w ith a lOO-fold 
molar excess of unlabel ed oligonucleotide before the addition of 
32P-labeled RARE. The unlabeled o ligonucleotide contains the 
consensus binding site for the R.AR protein. As shown ill Fig SB, 
the unlabeled RAR consensus oligonucleotide competed effec-
tively with the 32P_labeled RARE (1-om the rat proa l (I) collagcn 
promoter for binding to the RAR y protein. 
t -RA Treatment of FRS Fibroblasts Decreases Nuclear 
Binding to the RARE W e used the gel mobility shift assay to 
study the binding of nuclear proteins isolated from control and 
t-RA-treated fibroblasts to the RARE sequence (Fig 6). Fig 6A 
and B represent two diffcrent experiments. t-RA treatment of 
non-transfected FRS fibroblasts decreased the binding of isolated 
nuclear proteins to the 32P_labeled oligonucleotide (5' -AAGT A-
GAGTGGGGGTCAGGCAGAGCACC-3') containing the RARE 
balf-site (5'-GGGTCA-3') to 30'X, of the binding observed when 
cells were untreated (Fig 6A) and in a second experiment to 33% 
of control values (Fig 6B) . When the 6-bp sequence 5' -
GGGTCA-3' in the oljgonucleotide was replaced with the se-. 
quence 5'-TATGAC-3' (mRARE) , the binding of the nuclear 
proteins isolated from t-RA-treated fibroblasts decreased to 5% of 
control value and to 9% of the value found with the non mutated 
probe. There was a 45% decrease in binding of nuclear protein from 
untreated cells to the probe containing the mutated RARE whereas 
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Figure 5. Purified RAR l' binds to a RARE in the proal(I) collagen 
promoter. (A) 32P-cnd-labcled double-stranded oligonucleotide contain-
ing the RARE half-site sequence (S'-GGGTCA-3 ' ) (1.2 X 106 M cpm per 
pmol) was incubated with 200 ng of purified RAR 'Y. In addition. each assay 
mixture contained 0.2 ILg ofpoly[d(I-C)] and 6 ILg of bovine serum albumin 
in a total volume of 20 ILl. After a 20-min incubation at room temperature. 
2 ILl of R.AR 'Y antibody (1 mg per ml) were addcd to the reaction mixture 
and incubatio n was continued for an additional 45 Inin at r00l11 tClllperaturc. 
In a competition experiment (B), 100 ng of purified RA R 'Y were incubated 
with 100-fold molar excess of unlabeled RAR consensus oligonucleotide 
before the addition of labeled RARE from the proal (I) coHagen promoter. 
Complete sequence of the oljgonucleotide containing the RARE in the rat 
proa l (I) colh.gen promoter ITom positions - 1346 to - 1319 (S'-AAGTA-
GAGTGGGGGTCAGGCAGAGCACC-3'); complete sequence of the 
[tAR ol.igonucleotide that contains the binding site for the RAR (5 ' -
AGGGT AGGGTTCACCGAAAGTTCACTC-3 ') . 
(Fig 4) the binding of the nuclear receptors RAR y and RXRa was 
elimjnated with the mutated RARE. Because nuclear extracts £i'om 
untreated cells are composed of many proteins, some may react 
with the mutated .RARE sequence. RARy and RXRa are pure 
protein preparatio ns and thus would not react with a oligonucleo-
tide containing a mutated RARE. 
Specific Complex Formation Between Nuclear Proteins 
from FRS Fibroblasts and RAR and RXR Consensus Oli-
gonucleotides Gel mobility sh.ift assays were llsed to show that 
nuclear extracts contain RAR and RXR proteins . We found that 
nuclear proteins derived from untreated cell s bound to the 32p_ 
labe led oLigonucleotide that contajns the consensus binding site for 
the RAR (5'-AGGGTAGGGTTCACCGAAAGTTCACTC-3') 
(Fig 7A) . Two bands were found and were simjlar to those found 
when recombinant and purified recombinant RAR y were reacted 
with the RARE ti'om the proa l (I) collagen promoter (Figs 4 and 
5, respectively) . The binding of nuclear extract to the 32P-labeled 
RAR consensus oligonucleotide in the presen ce oflOO-fold molar 
excess of the unl abe led RARE from the rat proa1(J) collagen 
promoter changed the binding pattern. A sin gle band was found. 
The nuclear extract de rived from untreated cells also bound to a 
32P-labeled oEgonucleotide that contains the consensus binding site 
for the RXR (5 '-AGCTTCAGGTCAGAGGTCAGAGAGCT-3') 
(Fig 7B) . A lOO-fold molar excess of the unlabeled RARE fiom the 
rat proal(l) collagen promoter reduced the binding of nuclear 
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Figure 6. t-RA decreases nuclear prote in binding to the RARE. 
Confl uent FR S fib roblasts were treated wi th 10- 6 M t-RA for 48 h. (A) 
32P_end_labelcd double-stra nded oligonucleotide containing the RA l i 
half-site sequence (5'-GGGTCA-3') (2 .3 X 106 Cplll per 1'11101) or the 
mRARE half-site sequence (5'-TATGAC-3') (2.8 X 106 Cplll per pmol) 
was incubated with 10 p.g of nuclear protein extract and 1.5 p.g of 
poly[d(I-C)] in buffer described in Mater;als alld MetllOds. In a second 
experiment (B), l O p.g of nuclear prote in extract were incubated wi th 
32P-cnd- labeled double-stranded oligonucleotide (2.6 X 106 Cplll per pmol) 
containing the RARE half-s ite sequence (5' -GGGTCA-3'). T he nuclear 
protein-oligonucleotide complex is indicated by the ->. Complete se-
quence of the o ligonucleotide conta ining the 1~ l i in the ra t proal(l) 
~o ll agen promoter from positions - 1346 to - 131 9 is 5'-AAGTAGAGT-
GGGGGTCAGGCAGAGCACC-3'; complete sequence of the oligonucle-
otide conta ining the mRA R.E is 5'-AAGTAGAGTGGTATGACGGCA-
GAGCACC-3'. 
extract to the 32P-I abeled RXR consen sus o ligonucl eotide. Incom-
plete competition of the unl abe led R ARE from the proa l (I) 
collagen promoter with a labe led oligonucleotide that conta ins the 
R A R consensus sequence could be due to the high affini ty ofRAR 
prote ins w ith 1'l.A REs that are direc t repea ts and are separa ted by 
fi ve nucleotides (Mangelsdorf ct ai, 1994) . Likew ise, incomple te 
com petitio n of the unl abeled l'l.ARE from the proa l (I) collagen 
pro m o te r w ith a labeled o ligonu cleotide th at contains th e RX.R 
con sensus sequ ence could be due to the high affini ty of R X R 
pro tei ns wi th re tin o id X response e lem en ts that are direct repeats 
and arc separated by o ne nucl eotide (Mangelsdo rf et til , 1994). 
DISCUSSION 
In th e CllITent study, we explored the m o lecul ar m echanism by 
w hich t-RA regula tes proa l (I) collagen gen e express io n . Previo us 
studies ha ve sh o wn th at t-RA decreases coll agen syn thesis in 
norm al and d isease sta tes. T he m echanism by w hich re tino ids 
decrease proa l (I ) coll agen gen e express ion m ay also apply to 
hypertro phic sca rs and ke lo ids, two cutan eous disorde rs character-
ized by excessive coll agen depositio n Oan ssen, 1980) . R etin o ids 
have been fo und to stimula te coUagen syn thes is wh en skin is 
recovering fro m injuries such as those indu ced by w o un din g, 
ul tr avio let rad iatio n , or glucocorticoid-indu ced skin atrophy (as 
described in a review by Gendime nico and M ezick, 1993) . 
W e have dem onstrated that t-R A do wnregula tes p roa l(l) col-
lagen gene transcriptio n in a time- and concen tration-dependent 
m an ner in stabl y transfected FR S fibro blasts . t-l'l.A at 3n equivalen t 
m o l.ar concen tra tio n was more effec tive in redu cing CAT ac tivi ty 
thaJl dexam ethason e (data not shown ). A previous study fro m o ur 
laboratory (M eisle r et ti l , 1995) dem o nstrated that glucocorticoids 
were able to bring the TGF-/3-indu ced in crease in C AT ac tivi ty 
back to contro l values. Unlike the g lucocorticoid, dexameth asone, 
t-RA used in combin ation w ith TGF-{3 lo w ered CAT activi ty 
~ 
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Figure 7. Nuclear proteins bind to RAR and R.XR consensus 
oligonucleotides. (A) 32P-end-Iobcled double-stranded oligonucleotide 
conta in ing the consensus binding site for the RAR (3.5 X '1 05 cpm per 
pmol) was incubated with 10 p.g of nuclear protein extract and 1.5 fl.g of 
poly[d(J-C)] in buffer described in Materials alld Merl/()ds. 1n a competition 
experiment, 10 p.g of Iluclear extract were incubated with] aD-fo ld molar 
excess of unlabeled RARE &om the proa1 (I ) co llagen promoter before d,e 
addi tion of labeled consensus RA R oligonucleotide. T he -> indicates the 
band corresponding to the nuclear protein- oligonucleotide complex that is 
eliminated in the competition experimen t. (8) 32P-elld-labcled double-
stranded o ligonucleotide cO l1 ta in.ing the con sen SLI S bindin g site fo r the R.X..R 
(4.9 X 105 cpm per pmol) was incubated with 10 p.g of nuclear protein 
extract and 1.5 }Lg of poly[d(I-C)] in a to tal volulIlc of 20 1-'1. In a 
competition experiment. 10 p.g of nuclear cxtnlct were incubated with 
l aO-fold molar excess of un label cd I~RE from the procr l (I) collagen 
promoter before the addition of labeled COllsensus RXR oligonucleotide. 
Complete sequence of the l~R oligonucleotide that contai ns the binding 
site for the R AR is 5'-AGGGTAGGGTTCACCGAAAGTTCACTC-3' ; 
complete sequence of the lU ll.. oligonucleotide that contaillS the binding 
site for RX R is 5'-AGCTTCAGGTCAGAGGTCAGAGAGCT-3'; COIll-
plete sequence of the oligonucleotide conta in.ing the R.Alli in the rat 
proal (I ) co llagen promoter from positions - 1346 to - 1319 is 5' -AAGTA-
GAGT GGGGGTCAGGCAGAGCACC-3' . 
be lo w the control value at aU concentra ti.ons tested . T his latter 
findin g sugges ts th at t-l'l.A m ay ha ve som e utili ty as an agent to 
redu ce fi b rosis induced by T GF-{3. Whether o r n ot t-RA can 
reduce excessive collagen produc tio n ill /); /)0 w ill need to be veri fied 
with m o dels of kelo ids, fibrosis, o r scalTing . 
T his study ind icates by ge l m o bili ty shi ft assay that t-RA 
decreases recep tor bound to the .lURE. T he RARE was shown to 
bind to bo th recombinant RAR l' and R X R a in ge l mobili ty shi ft 
assays . Mu ta tio n o f the consensus RARE half site (5 ' - GGGTCA-
3 ' ) e liminated recepto r binding (Fig 4) . It is not surprising that both 
I'l.AR l' and RXRa bind to the l'l.ARE, as RARs and RXR s foml 
he te rodim eric complexes in the absen ce o r presen ce o fli gand (Leid 
el ai, 1992a; Allen by el ti l , 1993; M al1 ge lsdo rf et ai, 1994). T he fact 
that nucl ear pro te ins iso lated fro m untreated cell s bind to the 
R ARE (Fig 6) and to RAR and RXR consensus o ligonucleotides 
(Fig 7) impli es that th e re is an endogenous level of re tinoid 
recepto r presen t in FRS fibrobl as ts. Pan and Brincke rhofF (1 994), in 
studying t-l'l.A inhibitio n of coll agenase gene express ion in synovial 
fib roblasts, show ed th at RX R .a mRN A is consti tu tive ly expressed 
and that the mRNAs fo r RARa, {3 and, l' are inducible by the 
addition of t- l'l.A. T hey suggest that l'l.ARs and R.XRs repress 
transcripti on of the collagenase gene by interfe ring w ith the binding 
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of the transcription factor AP-l (C-jllll /C-JOS ) to the 5' regulatory 
region of the collagenase gene . T he interference by retinoid 
receptors with other positi ve-acting transcriptio n fa ctors is thought 
to be the m echani sm by whi ch genes are negatively regulated by 
t-RA (Gudas ef nl, 1994; Mangelsdorf el nl, 1994). Our studies 
indica te, however, that the downregulation of p roa1 (I) gene 
expression is associated with a decrease in binding of nuclea r 
proteins isolated fr0111 t-RA- treated fibrobla sts to the RARE 
sequence in the 5' Ranking region of the gene. 
We have previously dem onstrated , using gel m o bili ty shift 
assays, that g lucocorticoid treatm ent of FRS fibro blasts decreased 
glucocorticoid receptor binding to the glucocorticoid response 
element and TGF-/3 activator protein to the TGF- /3 elem ent 
contained in the 5' Ranking region of the proal (I) collagen gene 
(Meisler el nl , 1995). Since retin o id receptors are m embers of the 
steroid/thyroid hormone receptor superfamily, one would expect 
that genes that are negatively regulated by t-RA would also show 
decreased binding of receptors to the RARE. Additional support of 
our hypothesis com es rrom studies on the human K5 keratin gene 
(Ohtsuki el nl, 1992). T he promoter seque nce for the human K5 
keratin gene has seve ral individual consensus half- sites recognized 
by RATts. H e La cell s were co-trallSfected with plasmid cons tructs 
containing the half- sites and vectors expressing RARs. T reatment 
with t-RA decreased promoter activity of the CAT constructs. 
Thus regulation of the K5 keratin gene by retinoids is e ffected by 
interaction of nuclear receptors fo r t-RA with RARE sequences 
w ithin the promoter. 
I¥e thnllk BOllllie Sclllllitt .Ii,,' the prq)(lrnti() lI '!I lh is 'II nllllscript. IVe Ihnllk Drs. 
D. W. Rowe nlld A. Liclttlerfor dOllatillg tlt e C"ICnIJ .6 plnslll id nlld Dr. J ell -FII 
Ch ill fo r prollidillg the RA R:y nlld JU<Ra, pm!ei"". T hese stlldies ,perc sIIppo,1ed It)' 
Ihe NnlicJ/lnl Jll slilllll'S '!F H enliit CI'nlll AR 40154. 
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